ARTICLE | Product Development
Non-profit biotech aims to revive stalled ultrarare therapies
Orphan Therapeutics Accelerator will pursue hybrid non-profit, commercial model
March 20, 2024 10:03 PM UTC
A team of patient advocates and biotech veterans will soon announce the creation of the Orphan Therapeutics Accelerator, a non-profit biotech that will acquire and try to revive stalled ultrarare therapies.
The accelerator is an unusual response to a vexing problem. ...